Skip to content

HYBRID: Hydrogen Breath Test in Lactose Digestion

A Randomized, Controlled, Double-blind, Cross-over, Single-centre Study to Investigate the Effect of a Fermented Infant Formula on Lactose Digestion in Lactose Intolerant Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02703987
Acronym
HYBRID
Enrollment
30
Registered
2016-03-09
Start date
2015-11-30
Completion date
2016-06-30
Last updated
2020-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactose Intolerance

Brief summary

The purpose of this study is to investigate the effect of a fermented infant formula on lactose digestion in lactose intolerant adults.

Interventions

OTHERFermented infant milk formula
OTHERNon-fermented infant milk formula

Sponsors

Danone Asia Pacific Holdings Pte, Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
21 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

BMI between 18.5 and 24.9 kg/m2 inclusive Lactose intolerant The following criteria need to be checked at visit 2: * Lactose intolerance confirmed by positive Hydrogen Breath Test (HBT) (i.e. if there are two or more samples with hydrogen level \> 20 ppm increase compared to baseline sample between 90 mins and 240 min sampling time point). * At least one sample with hydrogen level \> 20 ppm increase compared to baseline between 90 mins and 180 mins sampling time point.

Exclusion criteria

History of gastrointestinal disorders Current illness which could interfere with the study (e.g. diarrhea, regurgitation) Any history of cow's milk protein allergy or known allergy to galacto-oligosaccharides Any current participation or within 8 weeks of study start, in any other study involving investigational or marketed products, any medical procedures, or any surgical methods. Any antibiotic, laxative or colonic cleansing treatments within 4 weeks of study start Any administration of probiotic in the 1 week prior to study start Investigator's uncertainty about willingness or ability of subject to comply with protocol requirements The following criteria need to be checked at visit 2: * Level of hydrogen \> 20 ppm in the baseline breath sample. * An early peak of hydrogen (i.e. hydrogen level \> 20 ppm increase compared to baseline value) in the first 60 minutes after ingestion of the study products.

Design outcomes

Primary

MeasureTime frameDescription
Log of First Postprandial Peak Change of Hydrogen ConcentrationPostprandial peak hydrogen in breath within 4 hours after ingestion of study product; samples taken at 30 minute intervals for 4 hours, i.e. at 90, 120, 150, 180, 210 and 240 minutes at Visits 3 and 4This is measured as the log of the first change \>20ppm peak value compared to baseline between 90 minutes and 240 minutes. If there was no change \>20ppm at all between 90 minutes and 240 minutes, it is the maximum change compared to baseline in that interval
Log of Maximum Postprandial Change in Hydrogen ConcentrationMaximum postprandial hydrogen in breath within 4 hours after ingestion of study product; samples taken at 30 minute intervals for 4 hours, i.e. at 90, 120, 150, 180, 210 and 240 minutes at Visits 3 and 4This is measured as the maximum change in postprandial hydrogen concentration (ppm) compared to baseline between 90 minutes and 240 minutes

Secondary

MeasureTime frameDescription
Square Root of Postprandial Incremental Area Under Curve (iAUC) of Hydrogen Concentration From 30 Minutes to 240 MinutesHydrogen in breath within 4 hours after ingestion of study product; samples taken at 30 minute intervals for 4 hours, i.e. at 30, 60, 90, 120, 150, 180, 210 and 240 minutes at Visits 3 and 4The iAUC of hydrogen concentration from 30 to 240 minute sampling time points is calculated with the triangular rule (reference: Wolever TM. Effect of blood sampling schedule and method of calculating the area under the curve on validity and precision of glycaemic index values. Br J Nutr. 2004 Feb;91(2):295-301). The square root of the iAUC is then taken for the outcome measure

Countries

Singapore

Participant flow

Pre-assignment details

Two subjects were terminated before randomisation (1 due to sponsor decision to withdraw, and 1 due to consent withdrawal).

Participants by arm

ArmCount
Sequence 1
Test at visit 3, Control at visit 4
14
Sequence 2
Control at visit 3, Test at visit 4
14
Total28

Baseline characteristics

CharacteristicSequence 1Sequence 2Total
Age, Continuous30.0 years
STANDARD_DEVIATION 6.5
30.6 years
STANDARD_DEVIATION 4.6
30.3 years
STANDARD_DEVIATION 5.6
Race/Ethnicity, Customized
Chinese
13 Participants12 Participants25 Participants
Race/Ethnicity, Customized
Indian
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Malay
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Other
1 Participants0 Participants1 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
14 Participants14 Participants28 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 25
other
Total, other adverse events
26 / 2725 / 25
serious
Total, serious adverse events
0 / 270 / 25

Outcome results

Primary

Log of First Postprandial Peak Change of Hydrogen Concentration

This is measured as the log of the first change \>20ppm peak value compared to baseline between 90 minutes and 240 minutes. If there was no change \>20ppm at all between 90 minutes and 240 minutes, it is the maximum change compared to baseline in that interval

Time frame: Postprandial peak hydrogen in breath within 4 hours after ingestion of study product; samples taken at 30 minute intervals for 4 hours, i.e. at 90, 120, 150, 180, 210 and 240 minutes at Visits 3 and 4

Population: At Visit 3, 14 subjects took the control product and at Visit 4, 13 subjects took the control product. Therefore, 27 subjects took the control product in total.~At Visit 3, 14 subjects took the test product and at Visit 4, 11 subjects took the test product. Therefore, 25 subjects took the test product in total.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
ControlLog of First Postprandial Peak Change of Hydrogen ConcentrationBaseline1.21 log(ppm)Standard Error 0.1
ControlLog of First Postprandial Peak Change of Hydrogen ConcentrationPost-baseline3.38 log(ppm)Standard Error 0.08
TestLog of First Postprandial Peak Change of Hydrogen ConcentrationBaseline1.10 log(ppm)Standard Error 0.1
TestLog of First Postprandial Peak Change of Hydrogen ConcentrationPost-baseline3.59 log(ppm)Standard Error 0.09
p-value: 0.080195% CI: [-0.04, 0.67]Mixed Models Analysis
Primary

Log of Maximum Postprandial Change in Hydrogen Concentration

This is measured as the maximum change in postprandial hydrogen concentration (ppm) compared to baseline between 90 minutes and 240 minutes

Time frame: Maximum postprandial hydrogen in breath within 4 hours after ingestion of study product; samples taken at 30 minute intervals for 4 hours, i.e. at 90, 120, 150, 180, 210 and 240 minutes at Visits 3 and 4

Population: At Visit 3, 14 subjects took the control product and at Visit 4, 13 subjects took the control product. Therefore, 27 subjects took the control product in total.~At Visit 3, 14 subjects took the test product and at Visit 4, 11 subjects took the test product. Therefore, 25 subjects took the test product in total.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
ControlLog of Maximum Postprandial Change in Hydrogen ConcentrationBaseline1.21 log(ppm)Standard Error 0.1
ControlLog of Maximum Postprandial Change in Hydrogen ConcentrationPost-baseline3.70 log(ppm)Standard Error 0.1
TestLog of Maximum Postprandial Change in Hydrogen ConcentrationBaseline1.09 log(ppm)Standard Error 0.11
TestLog of Maximum Postprandial Change in Hydrogen ConcentrationPost-baseline3.93 log(ppm)Standard Error 0.11
p-value: 0.071495% CI: [-0.03, 0.71]Mixed Models Analysis
Secondary

Square Root of Postprandial Incremental Area Under Curve (iAUC) of Hydrogen Concentration From 30 Minutes to 240 Minutes

The iAUC of hydrogen concentration from 30 to 240 minute sampling time points is calculated with the triangular rule (reference: Wolever TM. Effect of blood sampling schedule and method of calculating the area under the curve on validity and precision of glycaemic index values. Br J Nutr. 2004 Feb;91(2):295-301). The square root of the iAUC is then taken for the outcome measure

Time frame: Hydrogen in breath within 4 hours after ingestion of study product; samples taken at 30 minute intervals for 4 hours, i.e. at 30, 60, 90, 120, 150, 180, 210 and 240 minutes at Visits 3 and 4

Population: At Visit 3, 14 subjects took the control product and at Visit 4, 13 subjects took the control product. Therefore, 27 subjects took the control product in total.~At Visit 3, 14 subjects took the test product and at Visit 4, 11 subjects took the test product. Therefore, 25 subjects took the test product in total.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
ControlSquare Root of Postprandial Incremental Area Under Curve (iAUC) of Hydrogen Concentration From 30 Minutes to 240 Minutes66.22 sqrt(ppm*min)Standard Error 4.42
TestSquare Root of Postprandial Incremental Area Under Curve (iAUC) of Hydrogen Concentration From 30 Minutes to 240 Minutes75.78 sqrt(ppm*min)Standard Error 4.59
p-value: 0.060995% CI: [-0.48, 19.6]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026